Skip to main content

Table 1 Sociodemographic, clinical, lifestyle, and health-care access patients’ baseline characteristics (N = 100)

From: Attrition and social vulnerability during 2-year-long structured care in type 2 diabetes, the ERMIES randomized controlled trial

 

Total

Complete follow-up

Attrition group

p value*

% miss

n (%)

% miss

n (%)

% miss

n (%)

 

Age, years; median [IQR]

-

59 [52.5–65]

-

60 [55–66]

-

56 [45–65]

0.002

Female

-

67 (67.0)

-

53 (71.6)

-

14 (53.9)

0.097

T2DM duration, years; median [IQR]

-

15 [10–24]

-

16 [11–24]

 

13 [8–20]

0.528

Chronic complications **

-

57 (57.0)

-

41 (55.4)

-

16 (65.4)

0.587

Microvascular

 

45 (45.0)

 

33 (44.6)

 

12 (46.1)

0.891

Macrovascular

 

33 (33.0)

 

21 (28.4)

 

12 (46.1)

0.097

Education level

-

 

-

 

-

 

0.242

 ≤ Primary school

 

48 (48.0)

 

39 (52.74)

 

9(34.6)

 

Middle school

 

31 (31.0)

 

20 (27.0)

 

11 (42.3)

 

 ≥ Secondary school

 

21 (21.0)

 

15 (20.3)

 

6 (23.1)

 

Cohabitation status

1

 

1.3

 

-

 

0.083

Living alone

 

26 (26.3)

 

23 (31.5)

 

3 (11.5)

 

Living with 1person

 

29 (29.3)

 

18 (24.7)

 

11 (42.3)

 

Living with 2 or more

 

44 (44.4)

 

32 (43.8)

 

12 (46.2)

 

Employment status

1

 

1.3

 

-

 

0.553

Part/full-time

 

27 (27.3)

 

23 (31.5)

 

11 (42.3)

 

Retired

 

39 (39.4)

 

20 (27.4)

 

7 (26.9)

 

Unemployed

 

34 (34.3)

 

30 (41.1)

 

8 (30.8)

 

Gross monthly household income

-

 

-

 

-

 

0.063

 < 800 euros

 

33 (33.0)

 

21 (28.4)

 

12 (46.2)

 

800–1999 euros

 

43 (43.0)

 

37 (50.0)

 

6 (23.1)

 

 > 1999 euros

 

22 (22.0)

 

15 (20.3)

 

7 (26.9)

 

unknown

 

2 (22.0)

 

1 (1.4)

 

1 (3.8)

 

Universal Health Coverage "CMU"

-

39 (39.0)

-

28 (37.8)

-

11 (42.3)

0.687

BMI class

-

 

-

 

-

 

0.972

18.5–24.9

 

13 (13.0)

 

10 (13.5)

 

3 (11.5)

 

25–29.9

 

43 (43.0)

 

31 (41.9)

 

12 (46.2)

 

 >  = 30

 

44 (44.0)

 

33 (44.6)

 

11 (42.3)

 

BMI. kg/m2 [median [IQR)]

-

28.6 [26.5–33.6]

-

28.6 [26.6–34.8]

-

28.9 [26.4–32.2]

0.224

Increased waist circumference a

1

74 (74.8)

1.3

56 (76.5)

-

18 (69.2)

0.451

HbA1c. % median [IQR]

-

8.8 [8.2–9.6]

-

8.7 [8.1–9.6]

-

9.0 [8.4–9.6]

0.899

Antidiabetic treatment

4

 

1.3

 

12.5

 

0.947

insulin ± oral treatment

 

59 (61.5)

 

45 (61.6)

 

14 (60.9)

 

oral treatment

 

37 (38.5)

 

28 (38.4)

 

9 (39.1)

 

Dietary imbalance b

1

56 (56.6)

1.3

44 (60.3)

-

12 (46.1)

0.212

Physical activity at home c

7

 

6.7

 

8.3

 

0.405

sedentary

 

57 (61.3)

 

44 (63.8)

 

13 (54.2)

 

Physical activity at work d

5

 

6.7

 

-

 

0.341

Unemployed

 

67 (70.5)

 

49 (71.0)

 

18 (69.2)

 

Sedentary work

 

15 (15.8)

 

9 (13.0)

 

6 (23.1)

 

Active work

 

13 (13.7)

 

11 (15.9)

 

2 (7.7)

 

Smoking

-

 

-

   

0.530

Nonsmoker

 

63 (63.0)

 

49 (66.2)

 

14 (53.9)

 

Smoker

 

9 (9.0)

 

6 (8.1)

 

3 (11.5)

 

Former smoker

 

28 (28.0)

 

19 (25.7)

 

9 (34.6)

 

NEMT in past year

5

24 (25.3)

5.3

14 (20.0)

4.2

10 (40.0)

0.048

Medical leave or hospitalization

in past year

2

32 (32.7)

1.3

20 (27.4)

4.2

12 (48.0)

0.058

Treatment compliance e

9

 

6.7

 

16.7

 

0.950

Good

 

18 (19.8)

 

14 (20.3)

 

4 (18.2)

 

Partially

 

47 (51.6)

 

35 (50.7)

 

12 (54.5)

 

Noncompliant

 

26 (28.6)

 

20 (30.0)

 

6 (27.3)

 

GP and diabetologist follow-up

5

 

5.3

 

4.2

 

0.876

 < 3 visits/year

 

16 (16.8)

 

12 (17.1)

 

4 (16.0)

 

3–4 visits/year

 

56 (58.9)

 

42 (60.0)

 

14 (56.0)

 

 > 4 visits/year

 

23 (24.2)

 

16 (22.9)

 

7 (28.0)

 
  1. Data are relative frequencies – n (%) for categorical variables and medians and interquartile range [IQR] for continuous variables
  2. Abbreviations: N Sample size, % miss Percentage of missing values, IQR Interquartile range, NEMT Nonemergency medical transportation, GP General practitioner, BMI Body mass index
  3. *Chi-square test for categorical and independent sample t test for continuous variables, respectively ** chronic complications correspond to history of stable chronic condition at baseline while presenting a severe evolving current complication at baseline was a criteria of noninclusion in ERMIES RCT
  4. aWaist circumference > 88 cm (female) or > 102 cm (male)
  5. bdietary score (0–6), dietary imbalance if > 3
  6. cPhysical activity at home score (5–20), sedentary if < 13/20
  7. dPhysical activity at work score (5–20), sedentary if < 13/20
  8. eTreatment compliance score (0–6), 0 = good, 1–2 partially, >  = 3 noncompliant
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us